wclc 2023 highlights: flaura2 and egfr exon20-targeting tkis
Published 10 months ago • 323 plays • Length 2:54Download video MP4
Download video MP3
Similar videos
-
1:42
highlights in adcs from wclc 2023
-
1:15
highlights in sclc at wclc 2023
-
2:50
highlights from wclc '22
-
0:44
highlights of wclc 2022
-
2:28
amivantamab in patients with egfr ex20ins-mutated nsclc
-
0:56
wclc 2024 promo
-
4:17
highlights on amivantamab after progression on osimertinib in egfr-mutated nsclc: mariposa-2
-
7:46
personalized therapies for patients with kras-mutant lung cancer
-
4:02
cancer care team awards from iaslc's 2023 wclc
-
17:58
cml highlights of ash 2023 - clinical overview
-
0:53
treatments for patients with nsclc carrying egfr exon 20 insertions
-
7:34
dr. somnath roy - analysis for patients with lung adenocarcinoma with egfr exon 20 insertions
-
0:27
wclc 2022 highlight
-
1:46
the evolving treatment landscape for nsclc with egfr exon 20 insertion mutations
-
10:30
expert highlights: targeting her2 and egfr in nsclc | tejas patil
-
0:35
data on kras inhibitors in lung cancer at wclc 2022
-
9:06
favour: furmonertinib in advanced nsclc with egfr exon 20 insertions | crsf 7th annual lung cancer
-
1:31
wclc 2021 highlights